Advertisement

ADVERTISEMENT

News

News
Phase I Study of PSMA Targeted 225Ac-J591 Reveals Tolerability in mCRPC
07/13/2021
225Ac-J591 receives first human study with research in PSMA targeting and dose expansion capabilities during an ongoing phase I trial.
225Ac-J591 receives first human study with research in PSMA targeting and dose expansion capabilities during an ongoing phase I trial.
225Ac-J591 receives first human...
07/13/2021
Oncology
Radiogland Therapy Demonstrates Promising Results in PSMA-Positive mCRPC
07/13/2021
177Lu-PSMA-617 met both primary endpoints and substantially improved OS and rPFS outcomes in patients with PSMA-positive metastatic castration-resistant prostate cancer, according to the phase III VISION study.
177Lu-PSMA-617 met both primary endpoints and substantially improved OS and rPFS outcomes in patients with PSMA-positive metastatic castration-resistant prostate cancer, according to the phase III VISION study.
177Lu-PSMA-617 met both primary...
07/13/2021
Oncology
Conference Insider
Ripretinib Yields Clinical Benefit; Proven Tolerability in Advanced GIST
06/17/2021
INVICTUS study results reveal intra-patient dose escalation (IPDE) of ripretinib after disease progression indicate clinical benefit and tolerability in patients with advanced gastrointestinal stromal tumors.
INVICTUS study results reveal intra-patient dose escalation (IPDE) of ripretinib after disease progression indicate clinical benefit and tolerability in patients with advanced gastrointestinal stromal tumors.
INVICTUS study results reveal...
06/17/2021
Oncology
Conference Insider
Experts Investigate Value of Chromosomal Complexity in Imatinib Treatment for High-Risk GIST
06/17/2021
Investigators sought to determine if chromosomal complexity could be used as a biomarker in de-escalation of adjuvant imatinib treatment, presented at the 2021 ASCO Annual Meeting.
Investigators sought to determine if chromosomal complexity could be used as a biomarker in de-escalation of adjuvant imatinib treatment, presented at the 2021 ASCO Annual Meeting.
Investigators sought to...
06/17/2021
Oncology
Press Release
MolecuLight Launches the i:X® Telemedicine Solution for Imaging of Bacteria in Wounds
07/16/2020
New Telemedicine Solution allows the MolecuLight i:X Device to be used at the Bedside for Synchronous Interpretation of the Images by Remote Wound Care Clinicians
New Telemedicine Solution allows the MolecuLight i:X Device to be used at the Bedside for Synchronous Interpretation of the Images by Remote Wound Care Clinicians
New Telemedicine...
07/16/2020
Wound Care
Press Release
MolecuLight Launches i:X® Sterile Surgical Sleeve for Imaging of Bacteria in Wounds in a Surgical Setting
07/09/2020
New Disposable Sleeve allows MolecuLight i:X to Be Used in Operating Rooms (for skin grafts and skin substitutes), in Covid-19 Wards and in MRSA Isolation Wards
New Disposable Sleeve allows MolecuLight i:X to Be Used in Operating Rooms (for skin grafts and skin substitutes), in Covid-19 Wards and in MRSA Isolation Wards
New Disposable Sleeve allows...
07/09/2020
Wound Care
Press Release
MTF Biologics Wound Care Tissue Forms Now Accessible to Over 240 Million Americans
06/22/2020
New positive coverage decisions with Aetna™, Centene Corporation®, WellCare® and Tufts Health Plan provide greater access to MTF Biologics Wound Care Tissues, AmnioBand® and AlloPatch®, to millions of Americans who suffer from complex and...
New positive coverage decisions with Aetna™, Centene Corporation®, WellCare® and Tufts Health Plan provide greater access to MTF Biologics Wound Care Tissues, AmnioBand® and AlloPatch®, to millions of Americans who suffer from complex and...
New positive coverage decisions...
06/22/2020
Wound Care
MolecuLight Announces CMS has Assigned an APC Reimbursement Code for its MolecuLight i:X®Procedure for Bacterial Imaging using Fluorescence 
Press Release
MolecuLight Announces CMS has Assigned an APC Reimbursement Code for its MolecuLight i:X®Procedure for Bacterial Imaging using Fluorescence 
06/11/2020
New Code Enables Facility Reimbursement to Hospital Outpatient Centers Performing MolecuLight’s Procedure, Benefiting Wound Care Patients
New Code Enables Facility Reimbursement to Hospital Outpatient Centers Performing MolecuLight’s Procedure, Benefiting Wound Care Patients
New Code Enables Facility...
06/11/2020
Wound Care
Interview
Net Health Discusses New Acquisition
05/26/2020
Listen to "Net Health Acquisition" on Spreaker.
Listen to "Net Health Acquisition" on Spreaker.
Listen to "Net Health...
05/26/2020
Wound Care
Press Release
Net Health Acquires Tissue Analytics
05/14/2020
Combines market leaders in wound care clinical documentation, wound imaging and predictive analytics
Combines market leaders in wound care clinical documentation, wound imaging and predictive analytics
Combines market leaders in wound...
05/14/2020
Wound Care

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use